Cover Picture: Arch Pharm (12/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202270025
- Publication type:
- Article
Works matching IS 03656233 AND DT 2022 AND VI 355 AND IP 12
Results: 16
1
2
Synthesis and biological evaluation of coumarin‐thiazole hybrids as selective carbonic anhydrase IX and XII inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200232
- By:
- Publication type:
- Article
3
Novel 2‐substituted thioquinazoline‐benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200180
- By:
- Publication type:
- Article
4
Editorial Board: Arch Pharm (12/2022).
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202270026
- Publication type:
- Article
5
Anticancer 5‐arylidene‐2‐(4‐hydroxyphenyl)aminothiazol‐4(5H)‐ones as tubulin inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200419
- By:
- Publication type:
- Article
6
Imaging of the calcium activated potassium channel 3.1 (K<sub>Ca</sub>3.1) in vivo using a senicapoc‐derived positron emission tomography tracer.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200388
- By:
- Publication type:
- Article
7
Synthetic flavagline derivative 1‐chloroacetylrocaglaol promotes apoptosis in K562 erythroleukemia cells through miR‐17‐92 cluster genes.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200367
- By:
- Publication type:
- Article
8
Mechanistic study of the antibacterial potential of the prenylated flavonoid auriculasin against Escherichia coli.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200360
- By:
- Publication type:
- Article
9
Phthalimide‐tethered imidazolium salts: Synthesis, characterization, enzyme inhibitory properties, and in silico studies.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200348
- By:
- Publication type:
- Article
10
Recent advances in the development of celecoxib analogs as anticancer agents: A review.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200326
- By:
- Publication type:
- Article
11
New PEPPSI‐Pd‐NHC complexes bearing 4‐hydroxyphenylethyl group: Synthesis, characterization, molecular docking, and bioactivity properties.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200276
- By:
- Publication type:
- Article
12
Quantum dots in the biomedical world: A smart advanced nanocarrier for multiple venues application.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200299
- By:
- Publication type:
- Article
13
Design, synthesis, and evaluation of novel 3,4‐isoxazolediamide derivatives for the combination treatment of azole‐resistant candidiasis.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200266
- By:
- Publication type:
- Article
14
Тhio‐containing pteridines: Synthesis, modification, and biological activity.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200252
- By:
- Publication type:
- Article
15
Strategies in synthetic design and structure–activity relationship studies of novel heterocyclic scaffolds as aldose reductase‐2 inhibitors.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200167
- By:
- Publication type:
- Article
16
Design, synthesis, acetylcholinesterase, butyrylcholinesterase, and amyloid‐β aggregation inhibition studies of substituted 4,4ʹ‐diimine/4,4ʹ‐diazobiphenyl derivatives.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 12, p. 1, doi. 10.1002/ardp.202200152
- By:
- Publication type:
- Article